29
Dr. Aftab Asif Associate Professor Department of Psychiatry

Anxiety

Embed Size (px)

Citation preview

Page 1: Anxiety

Dr. Aftab AsifAssociate Professor

Department of Psychiatry

Page 2: Anxiety

NORMAL ANXIETY &

PATHOLOGICAL TYPES OF ANXIETY

   Behavior Ability to function  Assessment by patient, friend &

clinician Neuropsychiatric Evaluation

Page 3: Anxiety

ANXIETY DISORDER  Panic disorder (with or with out agoraphobia) Specific phobia Special phobia Generalized anxiety disorder Obsessive-compulsive disorder Acute stress disorder Posttraumatic stress disorder   Anxiety disorder due to medical condition Substance-induced anxiety disorder

Page 4: Anxiety

    PSYCHOANALYTIC THEORIES:

   “Anxiety around ego to take defensive action against the pressure from

within”

Page 5: Anxiety

MAJOR CATEGORIES:

Depending on the nature of the feared consequences

Id or impulse anxiety Separation anxiety Castration anxiety Superego anxiety

Page 6: Anxiety

  BEHAVIOURAL THEORIES:

Conditioned response to a specific environmental stimuli.

Regular food Contaminated foodAllergy Desensitization

Page 7: Anxiety

BIOLOGICAL THEORIES:Biological events precede the psychological conflict

Autonomic nervous system Stimulation of ANS- like

Cardiovascular – tachycardia Muscular – headache Gastrointestinal – diarrhoea Respiratory – tachypnea

Page 8: Anxiety

NEUROTRANSMITTER:

Norepinephrine

Serotonin

GABA

Page 9: Anxiety

Norepinephrine:

Locus Ceruleus Pons  Limbic system Cerebral cortex Brainstem Spinal cord   Stimulation Fear

Page 10: Anxiety

- Adrenergic agonist

(Isoproternol)

 

2- Adrenergic antagonist (yohimbine)

= Increased pain attacks

  Clonidine (catapres) = Reduced pain

attacks

Page 11: Anxiety

SEROTONIN:

Raphe nuclei in rostral brainstem Cerebral cortex Limbic system Amygdala Hippocampus Hypothalamus Some drug involved with serotonin reduce the

anxiety level.

Page 12: Anxiety

GABA

Benzodiazepine inhance The level of GABA reduced

anxiety Benzodiazepine severe panic attacks

antogonist (flumazenil)

Page 13: Anxiety

BRAIN – IMAGING STUDY:CT/MRI --- some

increase in the size

of cerebral ventricles.

MRI – specific defect

in the tight temporal lobe.

PET/SPECT/EEG –

Abnormalities in frontal cortex.

Page 14: Anxiety

GENETIC STUDIES:

50% relatives

have panic

attacks

Page 15: Anxiety

NEUROANATOMICAL CONSIDERATIONS:

Limbic system

Increased concentration of GABA

Cerebral cortex

Frontal cerebral cortex Connected with Parahippocampal

cingulated gyrus hypothalamus Production of anxiety

Page 16: Anxiety

DIFFERENT DISORDER VARIES Wide range of medical conditioning: Hyperthyroidism Hypothyroidism Hypoparathyroidism Vit B12 deficiency Cardiac arrythmias Hypoglycemia 83 % of cardiomyopathy patient awaiting cardiac

transplantation have panic disorder. 25 % Parkinson’s disease hare panic attacks 25 % of chronic obstructive pulmonary disease

(COPD) have panic attacks

Page 17: Anxiety

Amphetamine Cocaine Caffeine

Substance Induced Anxiety Disorder

Page 18: Anxiety

Mixed anxiety/depression disorder

AD

DA

AD

A

D

Page 19: Anxiety

PANIC DISORDER

Epidemiology: Life time prevalence 1.5 to 3 % - panic disorder  4 % - panic attacks  Women Men

2-3 1

Mitral valve prolapse    Mid systolic dick on cardiac auscultation

   Prolapse of one of the mitral valve leaflets

   Heterogenous

Page 20: Anxiety

Drug Starting Dosage

Daily Dosing Range

Max. Dosage

CommonS. Effect

Imipramine

25 mg at bedtime

50-100 mg 150 mg Dry mouth, blurred vision, constipation, urinary hesitancy, othostasis, somnolence, anxiety, sexual dysfunction

Pheneizine 15 mg twice daily

30-90 mg 90 mg Dry mouth, drowsiness, nausea, anxiety/nervousness, othostatic hypotension, myoclonus, hypotension, myoclonus, hypertensive

Fluoxetine 10 mg 20-40 mg 60 mg Nausea, diarrhea, anxiety/nervousness, sexual dysfunction

Paroxetine 10 mg 20-40 mg 60 mg Nausea, diarrhea, anxiety/nervousness, sexual dysfunction somnolence

DRUGS USED FOR THE TREATMENT OF PANIC DIAORDER.

Page 21: Anxiety

Sertraline 25 mg 25-150 mg 60 mg Nausea, diarrhea, anxiety/nervousness, sexual dysfunction

Alprazolam

0.25-0.5 mg 3times daily

1.5-4.0 mg 6 mg/day Nausea, diarrhea, anxiety/nervousness, sexual dysfunction

Clonazepam

0.25-0.5 mg twice daily

1.5-4.0 mg 6 mg/day Somnolence, ataxia, memory problems, physical dependence,

withdrawal reactions

Page 22: Anxiety

PHOBIC DISORDERS

“A marked and persistent

fear that is excessive at

unreasonable, cued by

the presence or anticipation

of a specific object or

situation.”

Page 23: Anxiety

SPECIFIC TYPES: Animal type if the fear is cued by : Animals or insects

Natural environment type: Storms, heights or water

Blood-injection-injury type:

Situational type: Public transportation, tunnels, bridges, elevatos,

flying, driving, peak in childhood or in mid 20s

Page 24: Anxiety

SOCIAL PHOBIA: Exposed to unfamiliar people

or to possible scrutiny by others. EPIDIMIOLOGY: Phobic disorder – 5-10 % in

general population Social phobia – 3 %

Page 25: Anxiety

TREATMENT:

Pharmacological Treatment: Benzodiazepine -blockers Antidepressants.

Psychotherapy: Behavior or Cognitive behavior therapy

Page 26: Anxiety

GENERALIZEDANXIETY DISORDER (GAD)

Excessive anxiety and worry for at least 6months. SYMPTOMS: Restlessness or feeling

keyed up, on edge Difficulty concentration or mind going blank  Irritability Muscle tension  Sleep disturbance

Page 27: Anxiety

EPIDIMIOLOGY:

 Early adult life.  Commonly in women  More frequently in general Medical practice than in Psychiatry  High rate of comorbidity  Symptoms of hyperarousal  Do not recognize themselves as having

psychiatric illness

Page 28: Anxiety

DIFFERENTIAL DIAGNOSIS: Major depression OCD Panic disorder Somatoform disorder Paranoid Eating disorder Hyper thyroidism Hypothyroidism Diabetes Drugs Mitral valve prolapse     

Page 29: Anxiety

TREATMENT: Pharmacological treatment: Benzodiazepine

Buspirone(serotonin 1A receptor partial agonist)

TCA SSRI

Psychotherapy:– Cognitive – behavior therapy.